Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea2c70d1f9e89c870dc16fd138cb6511 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 |
filingDate |
2007-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa64a89d3c45e544691c680fad67f58b |
publicationDate |
2008-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2008004222-A1 |
titleOfInvention |
Antitumorigenic Drug Combination |
abstract |
Compositions comprising drugs having additive antitumorigenesis activity and methods of treatment using the combinations is disclosed. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017304410-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10561712-B2 |
priorityDate |
2006-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |